| (CCTG) CO.29 / DYNAMIC III | Circulating Tumor DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colon Cancer: A Multicentre Phase II/III Randomised Controlled Study (DYNAMIC III) | Goffin, Dr John | Open to recruitment | ACTRN12617001566325 |
| (CCTG) CRC.9 / NRG-GI005 | Phase II/III Study of Circulating tumOr DNA as a Predictive BiomarRker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA) | Meyers, Dr Brandon | Open to recruitment | NCT04068103 |
| (CCTG) PAC.3 / ALLIANCE A021806 | A Phase III Trial of Perioperative versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer | Serrano, Dr Pablo | Open to recruitment | NCT04340141 |
| (Merck) MK-7902-015 / LEAP 015 | A Phase 3, Randomized Study to Evaluate the Efficacy and Safety of Lenvatinib (E7080/MK-7902) plus Pembrolizumab (MK-3475) plus Chemotherapy Compared with Standard of Care Therapy as First-line Intervention in Participants with Advanced/Metastatic Gastroesophageal Adenocarcinoma. | Juergens, Dr Rosalyn | Open to recruitment | NCT04662710 |
| (Roche) MO42541 / IMbrave251 | A PHASE III, OPEN-LABEL, RANDOMIZED STUDY OF ATEZOLIZUMAB WITH LENVATINIB OR SORAFENIB VERSUS SORAFENIB OR LENVATINIB ALONE IN HEPATOCELLULAR CARCINOMA PREVIOUSLY TREATEDWITH ATEZOLIZUMAB AND BEVACIZUMAB | Meyers, Dr Brandon | Open to recruitment | NCT04770896 |
| (CCTG) CO.21 / CHALLENGE | A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patients With High Risk Stage II or Stage III Colon Cancer: A Randomized Controlled Trial (CHALLENGE) | Goffin, Dr John | Suspended/On hold | NCT00819208 |
Find a Trial
Contact Us